Aarti Pharmalabs Limited
₹758.25+0.13%Dec 16, 11:00 AM IST
AARTIPHARM•Health Technology•Pharmaceuticals: Major
Current Price
₹758.25+0.13%
Dec 16, 11:00 AM ISTMarket Cap₹6,715.6 Cr
Market Cap₹6,715.6 Cr
Business Overview
Aarti Pharmalabs Limited operates through 3 main business divisions including Xanthine Derivatives & Allied Products, CDMO & CMO Services, API & Intermediates.
Business Hierarchy Structure for Aarti Pharmalabs Limited
- Aarti Pharmalabs Limited
- Xanthine Derivatives & Allied Products
- Caffeine
- Theophylline Anhydrous
- Aminophylline
- Etophylline
- Theophylline
- CDMO & CMO Services
- Contract Development and Manufacturing of Drug Substances
- New Chemical Entities (NCEs)
- Active Pharmaceutical Ingredients (APIs)
- Regulatory Starting Materials (RSMs)
- Intermediates
- Lab Scale to Manufacturing Scale Services
- Clinical Phases (Ph-I/II/III) Services
- Launch Services
- Commercial Phase Projects
- Synthetic Route Design
- HPAPIs Manufacturing
- Cryogenic Reaction Services
- Hydrogenation Services
- Research and Manufacturing Services for APIs and Intermediates
- API & Intermediates
- Highly Potent Active Pharmaceutical Ingredients (HPAPIs)
- Anti-cancer
- Anti-asthma
- Anti-hypertensive
- Anti-diabetic
- Corticosteroids
- Cytotoxic Medicines
- Generic Intermediates
- Highly Potent Active Pharmaceutical Ingredients (HPAPIs)
- Xanthine Derivatives & Allied Products